Related articles:

Cancer Genetics Inc.: Precision Oncology Diagnostics Leader, Cancer Genetics, Inc. & Precision Therapeutics Company, Lantern Pharma, Inc. Announce Strategic Collaboration Focused on Drug Rescue & Repurposing Leveraging Genomics, Biomarkers & Artificial Intelligence Driven Development for Multiple Lead Oncology Compounds
January 17, 2017

Cancer Genetics Inc.: Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection
September 26, 2016

Cancer Genetics Inc.: Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry
September 20, 2016

Cancer Genetics Inc.: Cancer Genetics to Report Third Quarter Financial Results on Tuesday, November 10, 2015
November 03, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Receives Third Patent for Proprietary Genomic FHACT(R) Test, Further Advancing the Detection and Treatment of Cervical and Other HPV-Associated Cancers
October 28, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Finalizes Purchase of Los Angeles-based Molecular Profiling Laboratory, Response Genetics, Inc., Adding $10-$12M in Annual Revenue and Establishing a National Clinical Sales Footprint
October 12, 2015

Cancer Genetics Inc.: Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.
October 02, 2015

Cancer Genetics Inc.: Cancer Genetics Announces Strong First Quarter 2015 Results
May 12, 2015

Cancer Genetics Inc.: Cancer Genetics Enters Into Multi-Year Research Collaboration With Moffitt Cancer Center for Genomics-Based Prediction of Side Effects Associated With Chemotherapy
May 06, 2015

Cancer Genetics Inc.: Cancer Genetics to Report First Quarter Financial Results on Tuesday, May 12
May 05, 2015

Cancer Genetics Inc.: Cancer Genetics Announces Record Fourth Quarter and Full-Year 2014 Revenue
March 12, 2015

Cancer Genetics Inc.: Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12
February 26, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Launches Digital Platform to Enable Collaboration With Community Hospitals and Laboratories
January 20, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors
December 16, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations
December 10, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors
December 03, 2014

Cancer Genetics Inc.: Cancer Genetics Inc Receives Second Patent for Genomic Cervical Cancer Test; Strengthens Position of FHACT®
November 11, 2014

Cancer Genetics Inc.: Cancer Genetics Inc Receives Second Patent for Genomic Cervical Cancer Test; Strengthens Position of FHACT(R)
November 11, 2014

Cancer Genetics Inc.: Cancer Genetics Announces Strong Third Quarter With Growth Across All Categories
November 10, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10
October 30, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers
October 21, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Announces Collaboration With Leading Oncology Researchers at Columbia University to Identify Genomic Signatures, Biomarkers and Novel Treatments for MDS and AML
October 13, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. and Beth Israel Deaconess Medical Center Enter Into Collaboration to Correlate Genomic Profiles to Patient Outcome in Diffuse Large B-Cell Lymphoma
September 23, 2014